UBS Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
|
|||||
|
2025
Q1 | $965K | Sell |
|
|||||
|
2024
Q4 | $1.93M | Buy |
|
|||||
|
2024
Q3 | $149K | Buy |
|
|||||
|
2024
Q2 | $151K | Buy |
|
|||||
|
2024
Q1 | $57.4K | Buy |
|
|||||
|
2023
Q4 | $63.3K | Sell |
|
|||||
|
2023
Q3 | $30.5K | Sell |
|
|||||
|
2023
Q2 | $76.7K | Sell |
|
|||||
|
2023
Q1 | $101K | Buy |
|
|||||
|
2022
Q4 | $146K | Buy |
|
|||||
|
2022
Q3 | $95K | Sell |
|
|||||
|
2022
Q2 | $104K | Buy |
|
|||||
|
2022
Q1 | $64K | Sell |
|
|||||
|
2021
Q4 | $323K | Buy |
|
|||||
|
2021
Q3 | $416K | Sell |
|
|||||
|
2021
Q2 | $1.12M | Sell |
|
|||||
|
2021
Q1 | $1.87M | Buy |
|
|||||
|
2020
Q4 | $371K | Sell |
|
|||||
|
2020
Q3 | $875K | Sell |
|
|||||
|
2020
Q2 | $2.89M | Sell |
|
|||||
|
2020
Q1 | $2.73M | Buy |
|
|||||
|
2019
Q4 | $3.87M | Buy |
|
|||||
|
2019
Q3 | $414K | Sell |
|
|||||
|
2019
Q2 | $686K | Sell |
|
|||||
|
2019
Q1 | $997K | Sell |
|
|||||
|
2018
Q4 | $8.53M | Buy |
|
|||||
|
2018
Q3 | $3.15M | Buy |
|
|||||
|
2018
Q2 | $1.57M | Sell |
|
|||||
|
2018
Q1 | $8.02M | Buy |
|
|||||
|
2017
Q4 | $5.52M | Sell |
|
|||||
|
2017
Q3 | $5.22M | Sell |
|
|||||
|
2017
Q2 | $7.04M | Buy |
|
|||||
|
2017
Q1 | $3.57M | Buy |
|
|||||
|
2016
Q4 | $606K | Sell |
|
|||||
|
2016
Q3 | $684K | Buy |
|
|||||
|
2016
Q2 | $140K | Buy |
|
|||||
|
2016
Q1 | $190K | Sell |
|
|||||
|
2015
Q4 | $3.18M | Buy |
|
|||||
|
2015
Q3 | $1.48M | Buy |
|
|||||
|
2015
Q2 | $1.07M | Buy |
|
|||||
|
2015
Q1 | $58K | Sell |
|
|||||
|
2014
Q4 | $189K | Buy |
|